A pilot randomized controlled trial comparing a novel compassion and metacognition approach for schizotypal personality disorder with a combination of cognitive therapy and psychopharmacological treatment.

BMC Psychiatry · 2023 · PMC9942388 · PMID 36803673

Europe PMC DOI

hedged sentence

0.5900

closest p · 11.8× alpha

0.5900

boldest claim

The sentences

borderline significancep = 0.59not close (p > 0.1)

This would be consistent with a borderline significance ( p = 0.59) of the comparison between EG and CG for primary outcome (see Table 3 ).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.